0,536  0,023  5 Hydroxytryptamine release inhibitor
0,477  0,005  Interleukin 6 antagonist
0,400  0,024  Calcium channel activator
0,475  0,099  Antiinflammatory
0,367  0,022  Cyclic AMP phosphodiesterase inhibitor
0,411  0,070  Histamine release inhibitor
0,345  0,004  GABA C receptor rho-2 antagonist
0,428  0,095  Caspase 9 stimulant
0,346  0,014  Antialcoholic
0,391  0,063  Ulceration
0,326  0,006  CDK2/cyclin A inhibitor
0,359  0,041  Sensitization
0,325  0,018  Pneumotoxic
0,388  0,102  Alzheimer's disease treatment
0,315  0,048  Tumour necrosis factor alpha release inhibitor
0,344  0,089  GST A substrate
0,344  0,089  GABA C receptor rho-3 antagonist
0,300  0,057  DNA damaging
0,246  0,009  Beta amyloid protein antagonist
0,289  0,056  GST M1-1 substrate
0,291  0,060  Antipyretic
0,238  0,007  GABA C receptor antagonist
0,311  0,081  FMO1 substrate
0,359  0,130  MAP kinase 1 inhibitor
0,260  0,033  Neurotrophic factor enhancer
0,284  0,058  Antineoplastic (liver cancer)
0,225  0,005  GABA C receptor rho-1 antagonist
0,224  0,007  Platelet growth factor antagonist
0,276  0,060  Heart failure treatment
0,271  0,062  Antiamyloidogenic
0,292  0,094  ICAM1 expression inhibitor
0,248  0,051  RNA-directed DNA polymerase inhibitor
0,255  0,059  UGT1A6 substrate
0,266  0,072  Flavin-containing monooxygenase substrate
0,277  0,092  Caspase 3 stimulant
0,234  0,050  Non-steroidal antiinflammatory agent
0,212  0,029  ATPase inhibitor
0,216  0,034  Carcinogenic, group 3
0,190  0,009  CYP2A6 inhibitor
0,203  0,026  Topoisomerase I inhibitor
0,190  0,017  Antineoplastic alkaloid
0,330  0,158  Antineoplastic (solid tumors)
0,284  0,113  Inflammatory Bowel disease treatment
0,304  0,132  Antibacterial
0,245  0,075  Cardiovascular analeptic
0,301  0,135  MAP kinase kinase 6 inhibitor
0,313  0,146  Calcium channel L-type activator
0,237  0,073  Potassium channel blocker
0,210  0,051  Diabetic nephropathy treatment
0,235  0,078  DNA synthesis inhibitor
0,194  0,039  Arachidonic acid antagonist
0,168  0,013  Ankylosing spondylitis treatment
0,269  0,119  CYP3A4 substrate
0,177  0,028  Hearing loss treatment
0,222  0,073  Interleukin antagonist
0,187  0,042  Genotoxic
0,160  0,016  Glutamate (mGluR) antagonist
0,262  0,118  Vasodilator, peripheral
0,215  0,073  VCAM1 expression inhibitor
0,232  0,099  Amyotrophic lateral sclerosis treatment
0,226  0,095  Tyrosine 3 hydroxylase inhibitor
0,284  0,154  Antiparkinsonian
0,180  0,050  Protein kinase stimulant
0,191  0,062  UGT1A4 substrate
0,149  0,021  Porphobilinogen synthase inhibitor
0,142  0,013  Restless leg syndrome treatment
0,229  0,102  Transcription factor STAT3 inhibitor
0,182  0,055  Antiviral (Herpes)
0,189  0,064  Lipocortins synthesis antagonist
0,230  0,106  UGT2B4 substrate
0,229  0,106  Gastrin inhibitor
0,176  0,054  UGT2B15 substrate
0,141  0,019  Paget's disease treatment
0,273  0,151  CYP2C19 inhibitor
0,259  0,141  Immunosuppressant
0,259  0,141  CYP2C9 substrate
0,221  0,104  UGT1A9 substrate
0,253  0,136  Antineoplastic (small cell lung cancer)
0,223  0,109  Transcription factor STAT inhibitor
0,169  0,054  Pulmonary hypertension treatment
0,245  0,131  Transcription factor NF kappa B inhibitor
0,159  0,045  Antieczematic
0,225  0,111  CYP1A2 inhibitor
0,239  0,126  CYP3A4 inhibitor
0,208  0,096  NOS2 expression inhibitor
0,223  0,113  Radiosensitizer
0,135  0,026  GST T1-1 substrate
0,150  0,042  Ca2+-transporting ATPase inhibitor
0,190  0,082  5 Hydroxytryptamine 3E antagonist
0,126  0,020  Keratolytic
0,119  0,013  Sodium/hydrogen exchanger 5 inhibitor
0,123  0,018  ATPase (Vacuolar H+) inhibitor
0,170  0,066  Catenin beta inhibitor
0,186  0,082  UGT1A1 substrate
0,147  0,044  Autism spectrum disorders treatment
0,115  0,014  DNA gyrase inhibitor
0,126  0,025  Tourette's syndrome treatment
0,107  0,006  Potassium channel (Inward rectifier) blocker
0,143  0,042  Carcinogenic, group 2B
0,118  0,018  mTOR complex 2 inhibitor
0,139  0,039  TRPA1 agonist
0,169  0,070  UGT2B10 substrate
0,171  0,073  Phobic disorders treatment
0,178  0,081  Carcinogenic
0,124  0,028  Antihypermotility
0,161  0,067  Carcinogenic, group 1
0,302  0,210  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,152  0,064  MAP kinase 3 inhibitor
0,136  0,048  Menstruation disorders treatment
0,141  0,054  Topoisomerase II inhibitor
0,205  0,118  Proliferative diseases treatment
0,210  0,123  Renal disease treatment
0,131  0,046  Cyclin-dependent kinase 2 inhibitor
0,175  0,090  Cytotoxic
0,184  0,099  Antiparasitic
0,136  0,053  Gastritis treatment
0,087  0,004  DNA gyrase subunit A inhibitor
0,131  0,050  Microtubule formation inhibitor
0,154  0,073  Interferon gamma antagonist
0,122  0,042  Mental retardation treatment
0,154  0,075  Eye irritation, high
0,118  0,042  CDK/cyclin complex inhibitor
0,087  0,012  Topoisomerase II beta inhibitor
0,212  0,138  CYP1A2 substrate
0,166  0,093  Antirickettsial
0,181  0,108  Fibrosis treatment
0,221  0,147  Angiogenesis inhibitor
0,090  0,019  Protein kinase C beta inhibitor
0,133  0,063  Antismoking
0,100  0,031  Nicotinic alpha4beta2 receptor antagonist
0,216  0,148  Antineoplastic (brain cancer)
0,114  0,048  Dementia treatment
0,089  0,023  Phosphodiesterase VIII inhibitor
0,110  0,044  Posttraumatic stress disorder treatment
0,181  0,118  Antihypercholesterolemic
0,140  0,079  Acaricide
0,193  0,132  Huntington's disease treatment
0,145  0,085  CF transmembrane conductance regulator agonist
0,169  0,109  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,203  0,144  Antipsoriatic
0,100  0,041  Gastroesophageal reflux disease treatment
0,097  0,039  Granulocyte macrophage colony stimulating factor agonist
0,087  0,028  Secretase beta inhibitor
0,101  0,043  Ornithine decarboxylase inhibitor
0,153  0,096  3C-like protease (Human coronavirus) inhibitor
0,098  0,042  Bromodomain-containing protein 2 inhibitor
0,113  0,057  Interleukin 2 antagonist
0,119  0,064  Constipation treatment
0,115  0,061  DNA intercalator
0,132  0,078  Antineoplastic (squamous cell carcinoma)
0,076  0,023  Phosphodiesterase 1C inhibitor
0,105  0,052  Vascular dementia treatment
0,207  0,154  FMO3 substrate
0,090  0,037  Transforming growth factor beta 3 antagonist
0,110  0,058  Mediator release inhibitor
0,137  0,085  Heat shock protein 70 antagonist
0,186  0,134  Antineoplastic (ovarian cancer)
0,106  0,055  Anabolic
0,120  0,070  Growth stimulant
0,118  0,068  Antifungal (Pneumocystis)
0,103  0,053  Glutamate (mGluR7) agonist
0,152  0,103  Platelet adhesion inhibitor
0,052  0,004  Potassium channel (Inward rectifier) 1 blocker
0,135  0,088  Hemostatic
0,161  0,115  Platelet aggregation inhibitor
0,072  0,028  Glutamate (mGluR1) antagonist
0,157  0,113  I kappa B kinase epsilon inhibitor
0,188  0,145  Antiviral (West Nile virus)
0,083  0,040  Antidote, organophosphates
0,105  0,062  Antiviral (Poxvirus)
0,181  0,138  Interleukin agonist
0,224  0,183  TNF expression inhibitor
0,100  0,058  Obsessive-compulsive disorder treatment
0,149  0,107  Sleep disorders treatment
0,134  0,093  Heat shock protein 90 antagonist
0,118  0,077  Glutamate receptor antagonist
0,067  0,027  Neuropeptide Y5 antagonist
0,064  0,024  Acetyl-CoA transferase 2 inhibitor
0,098  0,058  Antineoplastic, alkylator
0,116  0,077  Antiviral (Influenza B)
0,081  0,042  Histidine decarboxylase inhibitor
0,118  0,080  Cyclooxygenase 3 inhibitor
0,122  0,084  Liver cirrhosis treatment
0,176  0,138  Nitric-oxide synthase stimulant
0,106  0,068  Excitatory amino acid transporter EAAC1 inhibitor
0,165  0,128  Antineoplastic (cervical cancer)
0,078  0,042  Phosphofructokinase-1 inhibitor
0,051  0,015  Glutamate (mGluR group II) antagonist
0,075  0,041  Bulimia treatment
0,115  0,082  DNA repair enzyme inhibitor
0,098  0,066  mTOR complex 1 inhibitor
0,079  0,046  NAT1 substrate
0,096  0,063  Interleukin 1 beta converting enzyme inhibitor
0,051  0,020  Glutamate (mGluR1a) antagonist
0,081  0,050  Na+ K+ transporting ATPase inhibitor
0,146  0,115  Antihelmintic
0,114  0,085  Coagulant
0,097  0,069  GABA C receptor agonist
0,120  0,093  Antimutagenic
0,113  0,085  Alpha-N-acetylglucosaminidase inhibitor
0,049  0,022  Guanylate cyclase inhibitor
0,156  0,129  Growth factor agonist
0,126  0,099  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,039  0,012  Glutamate (mGluR2) antagonist
0,165  0,139  Antineoplastic (renal cancer)
0,222  0,196  Rheumatoid arthritis treatment
0,069  0,044  Leukotriene synthesis inhibitor
0,072  0,047  Glutamate (mGluR group I) antagonist
0,072  0,048  Orexin receptor 1 antagonist
0,070  0,046  Phenylalanine 4-hydroxylase inhibitor
0,169  0,146  Spasmolytic
0,051  0,028  Cholesterol esterase inhibitor
0,141  0,118  Aldehyde oxidase substrate
0,086  0,064  Antidote, mercury
0,220  0,199  Antipruritic, allergic
0,031  0,009  Complement factor 1r inhibitor
0,081  0,059  Caspase 7 inhibitor
0,042  0,021  DNA gyrase subunit B inhibitor
0,162  0,142  Cytostatic
0,111  0,091  Antihyperlipoproteinemic
0,073  0,054  Phosphodiesterase VI inhibitor
0,066  0,046  Orexin receptor antagonist
0,041  0,021  Inosine monophosphate dehydrogenase inhibitor
0,104  0,084  Myasthenia Gravis treatment
0,154  0,135  Aldehyde oxidase inhibitor
0,054  0,035  Nicotinic alpha3beta2 receptor antagonist
0,150  0,131  Focal adhesion kinase 2 inhibitor
0,040  0,022  Antiviral (Bovine viral diarrhea virus)
0,051  0,034  Potassium channel (Inward rectifier) activator
0,103  0,085  Alkylator
0,061  0,044  Antimycoplasmal
0,049  0,032  Potassium channel (ATP-sensitive) activator
0,025  0,010  Inosine monophosphate dehydrogenase 2 inhibitor
0,106  0,090  Bipolar disorder treatment
0,046  0,031  Glutamate (mGluR5) agonist
0,097  0,082  Platelet activating factor antagonist
0,189  0,175  Cholesterol antagonist
0,118  0,104  Mannose-6-phosphate isomerase inhibitor
0,103  0,089  Antineoplastic antimetabolite
0,079  0,065  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,058  0,046  Phosphodiesterase 1A inhibitor
0,030  0,018  Nicotinic alpha4beta2 receptor agonist
0,086  0,074  MAO A inhibitor
0,051  0,040  GABA A receptor antagonist
0,071  0,060  Potassium channel (Tandem pore domain) blocker
0,089  0,079  UGT2B11 substrate
0,238  0,228  Apoptosis agonist
0,020  0,010  Alpha 2b adrenoreceptor agonist
0,052  0,042  GABA receptor antagonist
0,049  0,040  Aconitate hydratase inhibitor
0,045  0,036  Benzodiazepine inverse agonist
0,065  0,057  Exportin-1 inhibitor
0,143  0,136  Antineoplastic (glioma)
0,080  0,073  Hematopoietic
0,168  0,161  Respiratory analeptic
0,027  0,020  Glucosylceramidase stimulant
0,123  0,116  Antinephritic
0,041  0,034  Nicotinic receptor alpha3 subunit antagonist
0,143  0,138  HERG channel blocker
0,087  0,082  NAT2 substrate
0,052  0,047  Aromatase inhibitor
0,120  0,114  UGT1A3 substrate
0,056  0,051  Potassium channel intermediate-conductance Ca-activated blocker
0,019  0,015  Inosine monophosphate dehydrogenase 1 inhibitor
0,042  0,039  Potassium channel Kv1.3 blocker
0,028  0,024  Nicotinic alpha3beta4 receptor agonist
0,096  0,093  Activin receptor-like kinase 4 inhibitor
0,123  0,120  Pregnane X receptor agonist
0,164  0,161  5 Hydroxytryptamine release stimulant
0,042  0,040  Glutamate (mGluR group I) agonist
0,047  0,045  Anesthetic inhalation
0,118  0,116  UGT2B7 substrate
0,115  0,113  Antidote
0,108  0,107  Antineoplastic (carcinoma)
0,080  0,079  Platelet activating factor beta antagonist

